Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer’s disease detection
PLOS ONE · 14.02.2025 · 20 (2) · e0318998
DOI: 10.1371/journal.pone.0318998 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 14.02.2025. Verfasst von Hongjie Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Deep Learning, Neural Networks, Computer. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Health and Family Planning Commission of Lianyungang City, First Affiliated Hospital of Zhengzhou University.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a leading cause of disability worldwide. Early detection is critical for preventing progression and formulating effective treatment plans. This study aims to develop a novel deep learning (DL) model, Hybrid-RViT, to enhance the detection of AD. The proposed Hybrid-RViT model integrates the pre-trained convolutional neural network (ResNet-50) with the Vision Transformer (ViT) to classify brain MRI images across different stages of AD. The ResNet-50 adopted for transfer learning, facilitates inductive bias and feature extraction. Concurrently, ViT processes sequences of image patches to capture long-distance relationships via a self-attention mechanism, thereby functioning as a joint local-global feature extractor. The Hybrid-RViT model achieved a training accuracy of 97% and a testing accuracy of 95%, outperforming previous models. This demonstrates its potential efficacy in accurately identifying and classifying AD stages from brain MRI data. The Hybrid-RViT model, combining ResNet-50 and ViT, shows superior performance in AD detection, highlighting its potential as a valuable tool for medical professionals in interpreting and analyzing brain MRI images. This model could significantly improve early diagnosis and intervention strategies for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, China.
- College of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- Collaborative Research Center, Shanghai University of Medicine & Health Sciences, Shanghai, China.
- Department of Radiology, Jiading District Central Hospital Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.
- Department of Chinese and Bilingual Studies, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
ORCID-Profile: Temitope Emmanuel Komolafe, Nizhuan Wang
Förderung
- National Natural Science Foundation of China
- Health and Family Planning Commission of Lianyungang City
- First Affiliated Hospital of Zhengzhou University
- Hong Kong Polytechnic University Start-up Fund
Zitieren
APA
Yan, H., Mubonanyikuzo, V., Komolafe, T. E., Zhou, L., Wu, T., & Wang, N. (2025). Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer’s disease detection. PLOS ONE, 20(2), e0318998. https://doi.org/10.1371/journal.pone.0318998
Vancouver
Yan H, Mubonanyikuzo V, Komolafe TE, Zhou L, Wu T, Wang N. Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer’s disease detection. PLOS ONE. 2025;20(2):e0318998. doi:10.1371/journal.pone.0318998
BibTeX
@article{Yan2025,
author = {Yan, Hongjie and Mubonanyikuzo, Vivens and Komolafe, Temitope Emmanuel and Zhou, Liang and Wu, Tao and Wang, Nizhuan},
title = {Hybrid-RViT: Hybridizing ResNet-50 and Vision Transformer for Enhanced Alzheimer’s disease detection},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {2},
pages = {e0318998},
doi = {10.1371/journal.pone.0318998}
}
EUVIMED